Becton, Dickinson & Co. (BDX)
207.11
-1.24
(-0.60%)
USD |
NYSE |
Jan 16, 16:00
207.12
+0.01
(+0.00%)
After-Hours: 20:00
Becton, Dickinson Free Cash Flow: 2.67B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| West Pharmaceutical Services, Inc. | 379.10M |
| Abbott Laboratories | 6.917B |
| Boston Scientific Corp. | 3.824B |
| Accuray, Inc. | 11.11M |
| Insulet Corp. | 407.70M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.354B |
| Cash from Investing (Quarterly) | -494.00M |
| Cash from Financing (Quarterly) | -809.00M |
| Free Cash Flow Per Share (Quarterly) | 3.490 |
| Free Cash Flow to Equity (Quarterly) | 323.00M |
| Free Cash Flow to Firm (Quarterly) | 1.152B |
| Free Cash Flow Yield | 4.47% |